CN106716138B - 用于确定细胞年龄的系统和方法 - Google Patents

用于确定细胞年龄的系统和方法 Download PDF

Info

Publication number
CN106716138B
CN106716138B CN201580048799.4A CN201580048799A CN106716138B CN 106716138 B CN106716138 B CN 106716138B CN 201580048799 A CN201580048799 A CN 201580048799A CN 106716138 B CN106716138 B CN 106716138B
Authority
CN
China
Prior art keywords
hba1c
fraction
cell
value
red blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201580048799.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN106716138A (zh
Inventor
安德里斯·范艾格斯霍芬
法布里斯·马莱格
克里斯托夫·戈德弗罗伊
恩里克·拉贝力诺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beckman Coulter Inc
Original Assignee
Beckman Coulter Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beckman Coulter Inc filed Critical Beckman Coulter Inc
Publication of CN106716138A publication Critical patent/CN106716138A/zh
Application granted granted Critical
Publication of CN106716138B publication Critical patent/CN106716138B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721Haemoglobin
    • G01N33/723Glycosylated haemoglobin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/14Optical investigation techniques, e.g. flow cytometry
    • G01N15/1456Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals
    • G01N15/1459Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals the analysis being performed on a sample stream
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • G01N33/492Determining multiple analytes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721Haemoglobin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721Haemoglobin
    • G01N33/726Devices
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/01Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
    • G01N2015/012Red blood cells
    • G01N2015/014Reticulocytes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/14Optical investigation techniques, e.g. flow cytometry
    • G01N2015/1402Data analysis by thresholding or gating operations performed on the acquired signals or stored data
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/14Optical investigation techniques, e.g. flow cytometry
    • G01N2015/1477Multiparameters
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/14Optical investigation techniques, e.g. flow cytometry
    • G01N2015/1488Methods for deciding
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/795Porphyrin- or corrin-ring-containing peptides
    • G01N2333/805Haemoglobins; Myoglobins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Ecology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN201580048799.4A 2014-09-12 2015-09-11 用于确定细胞年龄的系统和方法 Active CN106716138B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462049970P 2014-09-12 2014-09-12
US62/049,970 2014-09-12
US201462059684P 2014-10-03 2014-10-03
US62/059,684 2014-10-03
PCT/US2015/049797 WO2016040870A1 (en) 2014-09-12 2015-09-11 Systems and methods to determine the age of cells

Publications (2)

Publication Number Publication Date
CN106716138A CN106716138A (zh) 2017-05-24
CN106716138B true CN106716138B (zh) 2019-06-14

Family

ID=54238558

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201580048799.4A Active CN106716138B (zh) 2014-09-12 2015-09-11 用于确定细胞年龄的系统和方法

Country Status (5)

Country Link
US (1) US10739357B2 (enExample)
EP (1) EP3191848A1 (enExample)
JP (1) JP2017528715A (enExample)
CN (1) CN106716138B (enExample)
WO (1) WO2016040870A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3013360B1 (fr) * 2013-11-19 2015-12-04 Snecma Procede integre de frittage pour microfissuration et tenue a l'erosion des barrieres thermiques
SG11201908847TA (en) * 2017-03-31 2019-10-30 Life Technologies Corp Apparatuses, systems and methods for imaging flow cytometry
JP7254916B2 (ja) * 2018-10-26 2023-04-10 アボット ダイアベティス ケア インコーポレイテッド 生理学的パラメータ分析のための方法、デバイスおよびシステム
CA3157672A1 (en) 2019-11-25 2021-06-03 Abbott Diabetes Care Inc. Methods, devices, and systems for physiological parameter analysis
JP2021103139A (ja) * 2019-12-25 2021-07-15 ソニーグループ株式会社 情報処理装置、粒子測定装置、粒子測定システム、粒子分取装置、粒子分取システム、情報処理方法、及び情報処理プログラム
CN112305207B (zh) * 2020-10-20 2023-03-10 上海交通大学 基于HbA1c和血糖浓度为传感变量的红细胞平均寿命检测方法
WO2024094854A1 (en) * 2022-11-03 2024-05-10 Institut National de la Santé et de la Recherche Médicale Method for determining the relative age of red blood cells
WO2025210140A1 (en) * 2024-04-04 2025-10-09 Institut National de la Santé et de la Recherche Médicale Method for determining the age of red blood cells

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992017107A3 (en) * 1991-04-08 1992-11-12 Chronomed Inc Method and apparatus for analyzing the glycation of hemoglobin
US20070020612A1 (en) * 2005-02-07 2007-01-25 Beckman Coulter, Inc. Method of measurement of cellular hemoglobin
US20070267361A1 (en) * 2005-10-28 2007-11-22 Tyvoll David A Systems and methods for measuring glycated hemoglobin
WO2010019372A1 (en) * 2008-08-13 2010-02-18 Beckman Coulter, Inc. Reference control for cell by cell analysis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8481323B2 (en) * 2005-10-28 2013-07-09 Hewlett-Packard Development Company, L.P. Systems and methods for measuring glycated hemoglobin
EP2433140B1 (en) * 2009-05-20 2015-02-11 Relia Diagnostic Systems, Inc. Systems and methods for determining the percentage of glycated hemoglobin

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992017107A3 (en) * 1991-04-08 1992-11-12 Chronomed Inc Method and apparatus for analyzing the glycation of hemoglobin
US20070020612A1 (en) * 2005-02-07 2007-01-25 Beckman Coulter, Inc. Method of measurement of cellular hemoglobin
US20070267361A1 (en) * 2005-10-28 2007-11-22 Tyvoll David A Systems and methods for measuring glycated hemoglobin
CN101354327A (zh) * 2007-07-27 2009-01-28 惠普开发有限公司 测量糖化血色素的系统和方法
WO2010019372A1 (en) * 2008-08-13 2010-02-18 Beckman Coulter, Inc. Reference control for cell by cell analysis
CN102177437A (zh) * 2008-08-13 2011-09-07 贝克曼考尔特公司 用于逐一细胞分析的参考对照

Also Published As

Publication number Publication date
JP2017528715A (ja) 2017-09-28
US10739357B2 (en) 2020-08-11
CN106716138A (zh) 2017-05-24
WO2016040870A9 (en) 2017-04-06
WO2016040870A1 (en) 2016-03-17
EP3191848A1 (en) 2017-07-19
US20180231573A1 (en) 2018-08-16

Similar Documents

Publication Publication Date Title
CN106716138B (zh) 用于确定细胞年龄的系统和方法
Norlund et al. Reference intervals for the glomerular filtration rate and cell-proliferation markers: serum cystatin C and serum β2-microglobulin/cystatin C-ratio
Delanghe et al. The role of automated urine particle flow cytometry in clinical practice
Huskens et al. Standardization and reference ranges for whole blood platelet function measurements using a flow cytometric platelet activation test
Buoro et al. Biological variation of platelet parameters determined by the Sysmex XN hematology analyzer
McCaughey et al. Current methods of haemolysis detection and reporting as a source of risk to patient safety: a narrative review
Acker et al. An analysis of the bias in red blood cell hemolysis measurement using several analytical approaches
Joshi et al. Determining the stability of complete blood count parameters in stored blood samples using the SYSMEX XE‐5000 automated haematology analyser
Zhang et al. Biological variations of hematologic parameters determined by UniCel DxH 800 hematology analyzer
Cesano et al. Functional pathway analysis in acute myeloid leukemia using single cell network profiling assay: effect of specimen source (bone marrow or peripheral blood) on assay readouts
Kim et al. Quantitative evaluation of the real-world harmonization status of laboratory test items using external quality assessment data
Camburn et al. Myeloblasts in normal bone marrows expressing leukaemia-associated immunophenotypes
Lacher et al. Biological variation of hematology tests based on the 1999-2002 National Health and Nutrition Examination Survey
Petersen et al. The influence of analytical bias on diagnostic misclassifications
Bracho Reference intervals of automated reticulocyte count and immature reticulocyte fraction in a pediatric population
Duriancik et al. The identification and enumeration of dendritic cell populations from individual mouse spleen and Peyer's patches using flow cytometric analysis
Germain et al. First-Line screening of OXPHOS deficiencies using microscale oxygraphy in human skin fibroblasts: a preliminary study
Gaspar et al. Unique characteristics of leukocyte volume, conductivity and scatter in chronic myeloid leukemia
Lyon et al. Patient acuity exacerbates discrepancy between whole blood and plasma methods through error in molality to molarity conversion:“Mind the gap!”
Feng et al. Comparability evaluation of serum and plasma cytokine levels by multiplex bead-based flow cytometry
Poffenroth et al. The reticulocyte haemoglobin equivalent (RET_He) and laboratory screening for iron deficiency
Seabrook et al. Improving identification of caprine mandibles: Integrating morphological and ZooMS analyses
Üstündağ et al. Use of Mindray MC-80 digital morphology analyzer’s estimated platelet counts as adjunct to automated hematology analyzer
Nguyen et al. Application of reticulocyte-based estimation of red blood cell lifespan in anemia management of end-stage renal disease patients
Alkhaldy The Clinical Utility of Red Blood Cells and Reticulocyte-Related Indices for Early Detection of Latent Iron Deficiency

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant